Therapeutic TREM-1 peptides
US10603357B2 · kind B2 · utility
0Cited by
63References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 14, 2015 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | Aug 22, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.